T Cooke

1.6k total citations
25 papers, 1.2k citations indexed

About

T Cooke is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, T Cooke has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Cancer Research. Recurrent topics in T Cooke's work include HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Breast Cancer Treatment Studies (7 papers). T Cooke is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Breast Cancer Treatment Studies (7 papers). T Cooke collaborates with scholars based in United Kingdom, Canada and United States. T Cooke's co-authors include J. Reeves, Peter Stanton, John M.S. Bartlett, E. Mallon, Mitch Dowsett, Ian O. Ellis, James J. Going, Anna Lanigan, A.D. Watters and Angela Platt‐Higgins and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Annals of Oncology.

In The Last Decade

T Cooke

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T Cooke United Kingdom	15	865	526	520	318	117	25	1.2k
Rafael Molina Spain	18	1.1k 1.3×	476 0.9×	557 1.1×	473 1.5×	222 1.9×	33	1.7k
José Jiménez Spain	14	992 1.1×	407 0.8×	893 1.7×	268 0.8×	287 2.5×	39	1.6k
Robert B. Jenkins United States	5	734 0.8×	325 0.6×	215 0.4×	440 1.4×	222 1.9×	8	1.1k
Edward Clark United States	6	468 0.5×	223 0.4×	330 0.6×	279 0.9×	85 0.7×	6	764
G Boxer United Kingdom	20	309 0.4×	579 1.1×	563 1.1×	134 0.4×	110 0.9×	41	1.2k
CW Elston United Kingdom	12	921 1.1×	288 0.5×	382 0.7×	680 2.1×	182 1.6×	12	1.4k
Ossi R. Köchli Switzerland	10	861 1.0×	204 0.4×	773 1.5×	552 1.7×	247 2.1×	44	1.8k
Shyam M. Kavuri United States	10	751 0.9×	245 0.5×	381 0.7×	383 1.2×	318 2.7×	11	1.1k
C. Pallud France	18	700 0.8×	166 0.3×	387 0.7×	479 1.5×	110 0.9×	32	1.2k
S M Edgerton United States	13	1.1k 1.3×	183 0.3×	748 1.4×	661 2.1×	199 1.7×	14	1.7k

Countries citing papers authored by T Cooke

Since Specialization

Citations

This map shows the geographic impact of T Cooke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Cooke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Cooke more than expected).

Fields of papers citing papers by T Cooke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Cooke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Cooke. The network helps show where T Cooke may publish in the future.

Co-authorship network of co-authors of T Cooke

This figure shows the co-authorship network connecting the top 25 collaborators of T Cooke. A scholar is included among the top collaborators of T Cooke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Cooke. T Cooke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simon, Jessica, Sunita Ghosh, Daren K. Heyland, et al.. (2016). Evidence of increasing public participation in advance care planning: a comparison of polls in Alberta between 2007 and 2013. BMJ Supportive & Palliative Care. 9(2). 189–196. 12 indexed citations

Phipps, Kim, et al.. (2010). Frequency phenomenon and algorithms for arc detection. 183–188. 8 indexed citations

Marla, Sekhar, Patricia Roxburgh, Paul Burton, et al.. (2009). HER2 positive early breast cancers: tumour demographics and trastuzumab therapy in the real-world.. Cancer Research. 69(2_Supplement). 3159–3159. 1 indexed citations

Montgomery, David A., Katherine Krupa, Christopher R. Wilson, & T Cooke. (2008). Patients' expectations for follow-up in breast cancer – A preliminary, questionnaire-based study. The Breast. 17(4). 347–352. 16 indexed citations

Tovey, Sian, et al.. (2008). Activated c-Src kinase in oestrogen receptor positive breast cancer, nuclear location associated with improved patient outcome. An immunohistochemical analysis. European Journal of Surgical Oncology. 34(10). 1188–1189. 1 indexed citations

Fraser, Jennifer A., J. Reeves, Peter Stanton, et al.. (2003). A role for BRCA1 in sporadic breast cancer. British Journal of Cancer. 88(8). 1263–1270. 37 indexed citations

Watters, A.D., James J. Going, T Cooke, & John M.S. Bartlett. (2003). Chromosome 17 Aneusomy is Associated with Poor Prognostic Factors in Invasive Breast Carcinoma. Breast Cancer Research and Treatment. 77(2). 109–114. 107 indexed citations

Dowsett, Mitch, J. M. S. Bartlett, Ian O. Ellis, et al.. (2003). Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER‐2 in 426 breast carcinomas from 37 centres. The Journal of Pathology. 199(4). 418–423. 191 indexed citations

Lannigan, Alison, James J. Going, Eva Weiler-Mithoff, & T Cooke. (2002). Mucinous breast carcinoma. The Breast. 11(4). 359–361. 9 indexed citations

10.

Cooke, T, J. Reeves, Alison Lannigan, & Peter Stanton. (2001). The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker. European Journal of Cancer. 37. 3–10. 54 indexed citations

11.

Cooke, T, J. Reeves, Anna Lanigan, & Peter Stanton. (2001). HER2 as a prognostic and predictive marker for breast cancer. Annals of Oncology. 12. S23–S28. 122 indexed citations

12.

Watters, A.D., Michael W. Stacey, James J. Going, et al.. (2001). Genetic Aberrations of <i>NAT2</i> and Chromosome 8: Their Association with Progression in Transitional Cell Carcinoma of the Urinary Bladder. Urologia Internationalis. 67(3). 235–239. 7 indexed citations

13.

Dowsett, Mitch, T Cooke, Ian O. Ellis, et al.. (2000). Assessment of HER2 status in breast cancer. European Journal of Cancer. 36(2). 170–176. 92 indexed citations

14.

Ellis, Ian O., Mitch Dowsett, John M.S. Bartlett, et al.. (2000). Recommendations for HER2 testing in the UK. Journal of Clinical Pathology. 53(12). 890–892. 119 indexed citations

15.

Cooke, T, et al.. (1999). Quantitation of EGFR and c-erbB-2 expression in preinvasive compared to invasive breast cancer. European Journal of Cancer. 35. S203–S203. 9 indexed citations

16.

Robertson, Kevin, J. Reeves, Gillian Smith, et al.. (1996). Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.. PubMed. 56(16). 3823–30. 72 indexed citations

17.

Underwood, Mark A., et al.. (1996). Overexpression of p53 protein and its significance for recurrent progressive bladder tumours. British Journal of Urology. 77(5). 659–666. 29 indexed citations

18.

Going, James J., et al.. (1996). Quantitative radioimmunohistochemical measurements of p185(erbB-2) in frozen tissue sections.. Journal of Histochemistry & Cytochemistry. 44(11). 1251–1259. 17 indexed citations

19.

Cooke, T, Peter Stanton, Gordon Murray, et al.. (1992). Long-term prognostic significance of thymidine labelling index in primary breast cancer. European Journal of Cancer. 28(2-3). 424–426. 15 indexed citations

20.

Winstanley, John, et al.. (1991). The long term prognostic significance of c-erbB-2 in primary breast cancer. British Journal of Cancer. 63(3). 447–450. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact